Zura Bio Limited (ZURA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 16K | 0 | 0 | 0 | 0 | 5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -16K | 0 | 0 | 0 | 0 | -5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 25.5M | 18.41M | 19.52M | 18.06M | 19.25M | 15.73M | 19.32M | 11.76M | 8.38M | 10.83M | 10.19M | 33.91M | 7.72M | 1.07M | 927K | 412.33K | 514.5K | 321.86K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 10.75M | 7.46M | 7.57M | 9.36M | 8.78M | 6.49M | 13.29M | 6.22M | 4.79M | 3.91M | 6.22M | 5.67M | 2.83M | 653K | 842K | 412.33K | 514.5K | 321.86K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 14.75M | 10.96M | 11.95M | 8.7M | 10.47M | 9.24M | 6.03M | 5.54M | 3.59M | 6.92M | 3.96M | 28.23M | 4.88M | 415K | 85K | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -25.5M | -18.41M | -19.52M | -18.06M | -19.25M | -15.73M | -19.32M | -11.76M | -8.38M | -10.83M | -10.19M | -33.91M | -7.72M | -1.07M | -927K | -412.33K | -514.5K | -321.86K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -32.43% | -17.03% | -1.04% | -53.6% | -129.79% | -45.3% | -89.64% | 65.32% | -8.55% | - | -853.84% | -3557.5% | -1772.06% | -231.82% | - | - | - | - |
| EBITDA | -25.48M | -18.4M | -19.5M | -18.05M | -19.25M | -15.73M | -19.32M | -11.76M | -8.38M | -10.83M | -10.19M | -33.78M | -7.72M | -1.04M | -927K | 147.86K | 817.63K | 5.79M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -32.41% | -16.97% | -0.98% | -53.52% | -129.68% | -45.26% | -89.61% | 65.2% | -8.55% | - | -878.65% | -3544.33% | -5320.62% | -117.99% | - | - | - | - |
| D&A (Non-Cash Add-back) | 16K | 15K | 14K | 11K | 9K | 5K | 3K | 1K | 0 | 0 | 0 | 122.08K | 0 | 27.08K | 0 | 0 | 0 | 0 |
| EBIT | -25.5M | -18.41M | -19.52M | -18.06M | -19.25M | -13.63M | -19.32M | -11.76M | -8.38M | -10.83M | -10.19M | -33.91M | -7.72M | -1.07M | -927K | 147.86K | 817.63K | 5.79M |
| Net Interest Income | 1.32M | 1.28M | 1.53M | 1.72M | 1.82M | 2.13M | 2.46M | 2.2M | 1.22M | 1.37M | 815K | 0 | 1K | 0 | 0 | 16.31K | 12.16K | 6.95K |
| Interest Income | 1.32M | 1.28M | 1.53M | 1.72M | 1.82M | 2.13M | 2.46M | 2.2M | 1.22M | 1.37M | 815K | 0 | 1K | 0 | 0 | 16.31K | 12.16K | 6.95K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.28M | 1.24M | 1.48M | 2.07M | 1.81M | 2.11M | -1.38M | 1.43M | 632K | 2.35M | 1.92M | -120K | -2.08M | -34K | 2K | 560.18K | 1.33M | 6.11M |
| Pretax Income | -24.22M | -17.18M | -18.04M | -15.99M | -17.44M | -13.63M | -20.7M | -10.33M | -7.75M | -8.47M | -8.27M | -34.02M | -9.79M | -1.1M | -925K | 147.86K | 817.63K | 5.79M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -24.22M | -17.18M | -18.04M | -15.99M | -17.44M | -9.05M | -20.7M | -10.33M | -7.75M | -8.47M | -8.27M | -34.02M | -9.59M | -1.1M | -925K | 147.86K | 817.63K | 5.79M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -38.88% | -89.82% | 12.86% | -54.84% | -125.15% | -6.79% | -150.33% | 69.64% | 19.23% | - | -650.45% | -3578.38% | -6587.39% | -119.04% | - | - | - | - |
| Net Income (Continuing) | -24.22M | -17.18M | -18.04M | -15.99M | -17.44M | -13.63M | -20.7M | -10.33M | -7.75M | -8.47M | -8.27M | -34.02M | -9.79M | -1.1M | -925K | 147.86K | 817.63K | 5.79M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 10.2M | 13.2M | 13.2M | 13.2M | 17.78M | 15.54M | 13.2M | 20.22M | 22.42M | 22.42M | 10M | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.22 | -0.49 | -0.21 | -0.17 | -0.27 | -0.14 | -0.26 | -0.17 | -0.02 | -0.18 | -0.18 | -0.99 | -0.27 | -0.06 | -0.05 | 0.01 | 0.05 | 0.34 |
| EPS Growth % | 18.52% | -250% | 19.23% | 0% | -1630.77% | 22.22% | -44.44% | 82.83% | 94.22% | - | -181.69% | -1747.01% | - | -118.79% | - | - | - | - |
| EPS (Basic) | -0.22 | -0.49 | -0.21 | -0.17 | -0.19 | -0.14 | -0.26 | -0.17 | -0.02 | -0.18 | -0.18 | -0.99 | -0.27 | -0.06 | -0.05 | 0.01 | 0.05 | 0.34 |
| Diluted Shares Outstanding | 112.22M | 94.16M | 94.56M | 94.29M | 65.3M | 65.3M | 87.34M | 74.95M | 46.91M | 47.05M | 46.88M | 34.3M | 35.52M | 17.25M | 17.25M | 17.25M | 17.25M | 17.25M |
| Basic Shares Outstanding | 112.22M | 94.16M | 94.56M | 94.29M | 65.3M | 65.3M | 87.34M | 74.95M | 46.91M | 47.05M | 46.88M | 34.3M | 35.52M | 17.25M | 17.25M | 17.25M | 17.25M | 17.25M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |